0001732195-18-000002.txt : 20180226 0001732195-18-000002.hdr.sgml : 20180226 20180226110712 ACCESSION NUMBER: 0001732195-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180226 DATE AS OF CHANGE: 20180226 EFFECTIVENESS DATE: 20180226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SENTI BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001732195 IRS NUMBER: 812944208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-306382 FILM NUMBER: 18639063 BUSINESS ADDRESS: STREET 1: 329 OYSTER POINT BLVD 3RD FL CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 510-520-8691 MAIL ADDRESS: STREET 1: 329 OYSTER POINT BLVD 3RD FL CITY: SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001732195 SENTI BIOSCIENCES, INC. 329 OYSTER POINT BLVD 3RD FL SAN FRANCISCO CA CALIFORNIA 94080 650-382-3281 DELAWARE None None Corporation true 2016 Timothy Lu c/o Senti Biosciences, Inc. 329 Oyster Point Blvd 3rd Fl San Francisco CA CALIFORNIA 94080 Executive Officer Director Philip Lee c/o Senti Biosciences, Inc. 329 Oyster Point Blvd 3rd Fl San Francisco CA CALIFORNIA 94080 Executive Officer Ed Mathers c/o Senti Biosciences, Inc. 329 Oyster Point Blvd 3rd Fl San Francisco CA CALIFORNIA 94080 Director Alex Kolicich c/o Senti Biosciences, Inc. 329 Oyster Point Blvd 3rd Fl San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2018-02-09 true true false 0 53440771 39412199 14028572 false 26 0 0 400000 true The issuer anticipates that it will use a portion of the proceeds of the offering to pay compensation, which is currently expected to be approximately $400,000 per year in the aggregate, for the two executive officers named in Item 3 above. false SENTI BIOSCIENCES, INC. /s/ Timothy Lu Timothy Lu Chief Executive Officer 2018-02-23